Groundbreaking Method Destroys 99% of Cancer Cells, Study Reveals

A groundbreaking study conducted by scientists at Rice University in Texas unveils a novel method utilizing aminocyanine molecules, known as “molecular jackhammers,” effectively tearing apart cancer cell membranes upon activation, promising a staggering 99% efficiency in eliminating human melanoma cells in lab experiments.

Photo from Indy100

Innovative Cancer Treatment Discovery

Researchers discovered that aminocyanine molecules, conventionally used in medical imaging as synthetic dyes, exhibit the ability to rupture cancer cell membranes when triggered by near-infrared light, leading to promising outcomes in combating cancer.

The study’s results demonstrate an unprecedented 99% efficacy in eliminating human melanoma cells in laboratory settings, with nearly half of the mice treated for melanoma tumors displaying cancer-free status after receiving this innovative treatment.

Ciceron Ayala-Orozco, the lead author of the study, highlighted the groundbreaking potential of this approach, utilizing mechanical forces at the molecular level for cancer treatment and leveraging the biocompatible nature of these molecules.

READ ALSO: McKinsey Agrees To $78M Opioid Settlement With Health Insurers And Company Benefit Plans

Advancements in Cancer Therapy

The utilization of near-infrared light is pivotal as it facilitates deeper penetration into the body, offering potential non-surgical treatment avenues for cancers present in bones and organs, bypassing the need for invasive procedures.

This pioneering research, published in the Nature Chemistry journal, marks another significant stride in cancer treatment, following recent breakthroughs such as injecting a cancer-killing virus into humans and the development of self-destructing cancer cells.

Moreover, the pharmaceutical company Moderna has made strides with a vaccine significantly reducing the risk of death and recurrence in a type of skin cancer when combined with the immunotherapy drug Keytruda.

READ ALSO: Reflecting On The Top Health Stories Of 2023 In Boston: A Year Of Challenges And Innovation